Privia Health Posts $657M in Q3 Revenue, Topping Last Quarter's $632.6M
PRVA sits 16% above its 52-week low of $18.915 on elevated volume (2.3× avg).
Summary
Privia Health reported third-quarter revenue of $657M, up from $632.6M in Q2 2026 — roughly 3.9% sequential growth on top of the 21.4% year-over-year pace it posted last quarter. The quarter also brought earnings of 10c per share and adjusted EPS of 21c. Context matters here: the company just agreed on Nov. 2 to buy American Choice Healthcare MSSP from Cano Health for about $36M in cash, and Puma Growth Holdings disclosed a new 5.07% stake in September. Watch the full release and call for adjusted EBITDA and any change to full-year guidance, which will determine whether this revenue print is enough to hold the stock near $22.
At the time of this announcement, PRVA was trading at $22.00 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $18.92 to $28.82. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.